ARTICLE | Clinical News
Millennium files IND
June 12, 2000 7:00 AM UTC
MLNM filed an IND to begin U.S. Phase II testing of its LDP-02 humanized monoclonal antibody against integrin alpha(4)beta(7) to treat ulcerative colitis. The product also is in Phase II testing in Ca...